Condition

Glomerulosclerosis (2)

B-lymphocytes (1)

FSGS (1)

Focal Segmental Glomerulosclerosis (1)

Microbiota (1)

T-lymphocytes (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

ChemoCentryx (1)

Nantes University Hospital (1)

Collaborator

Medpace, Inc. (1)

Intervention

ccx140-b (1)

measurement of blood immune populations and microbiota distribution. (1)

placebo (1)

Study Documents

Intervention Type

other (2)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

glomerulosclerosis

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Cellules B et Microbiote Dans le SNI

Not yet recruiting

Microbiota
+3 more

Measurement of blood immune populations and microbiota distribution.

Nantes, Loire-Atlantique, France

Nantes University Hospital

Jan 10, 2022

FSGS, Focal Segmental Glomerulosclerosis, Glomerulosclerosis Trial in Worldwide (Placebo, CCX140-B)

Completed

FSGS
+2 more

Placebo
CCX140-B

Phoenix, Arizona
+37 more

Apr 2, 2021